Effects of different doses of adrenocorticotrophic hormone on the serum lipoprotein profile in healthy subjects

Basic and Clinical Pharmacology and Toxicology

Volumn 97, Issue 2, 2005, Pages 86-90

  Rafnsson, Arnar Thor ^a   Johannsson, Magnus ^b   Olafsson, Isleifur ^a   Dallongeville, Jean ^c   Erfurth, Eva Marie ^d   Berg, Anna Lena ^d   Arnadottir, Margret ^a  

^a LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^b UNIVERSITY OF ICELAND   (Iceland)

^c INSTITUT PASTEUR DE LILLE   (France)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; CORTICOTROPIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SODIUM CHLORIDE; TETRACOSACTIDE;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE CALCULATION; DOSE RESPONSE; DRUG EFFECT; EDEMA; HEART PALPITATION; HUMAN; LIPOPROTEIN BLOOD LEVEL; MALE; MULTIPLE DRUG DOSE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SKIN IRRITATION; SLEEP DISORDER; SWEATING; THIRST; URINALYSIS;

ADRENOCORTICOTROPIC HORMONE; ADULT; APOLIPOPROTEINS B; AREA UNDER CURVE; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; HYDROCORTISONE; INJECTIONS, INTRAMUSCULAR; LIPOPROTEINS; MALE; TRIGLYCERIDES;

EID: 22544447059     PISSN: 17427835     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2005.pto_108.x     Document Type: Article

References (17)

1. Arnadottir, M., A.-L. Berg, J. Dallongeville, J.-C. Fruchart & P. Nilsson-Ehle: Adrenocorticotrophic hormone lowers serum Lp(a) and LDL cholesterol concentrations but does not influence triglyceride metabolism in hemodialysis patients. Kidney Int. 1997, 52, 1651-1655.
2. Arnadottir, M., J. Dallongeville, P. Nilsson-Ehle & A.-L. Berg: Effects of short-term treatment with corticotropin on the serum apolipoprotein pattern. Scand. J. Clin. Lab. Invest. 2001, 61, 301-306.
3. Bartens, W., A. Krämer-Guth & C. Wanner: Corticotropin increases the receptor-specific uptake of native low-density lipoprotein (LDL) and native or oxidized lipoprotein(a) [Lp(a)] - in HEPG2 cells: no evidence for Lp(a) catabolism via the LDL receptor. Metabolism 1997, 46, 726-729.
4. Berg, A.-L., P. Hansson & P. Nilsson-Ehle: ACTH1-24 decreases hepatic lipase activities and low density lipoprotein concentrations in healthy men. J. Intern. Med. 1991, 229, 201-203.
5. Berg, A.-L. & P. Nilsson-Ehle: Direct effects of corticotropin on plasma lipoprotein metabolism in man - studies in vivo and in vitro. Metabolism 1994, 43, 90-97.
6. Berg, A.-L. & P. Nilsson-Ehle: ACTH lowers serum lipids in steroid treated hyperlipidemic patients with kidney disease. Kidney Int. 1996, 50, 538-542.
7. Berg, A.-L., P. Nilsson-Ehle & M. Arnadottir: Beneficial effects of ACTH on serum lipoprotein profile and glomerular function in patients with membranous nephropathy. Kidney Int. 1999, 56, 1534-1543.
8. Berg, A.-L. & M. Arnadottir: ACTH-induced improvement in the nephrotic syndrome in patients with a variety of diagnoses. Nephrol. Dial. Transplant. 2004, 19, 1305-1307.
9. Friedewald, W. T., R. I. Levy & D. S. Fredrickson: Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin. Chem. 1972, 18, 499-502.
10. Hardarson, A., G. Sigurdsson, E. Olafsdottir, J. Dallongeville, A.-L. Berg & M. Arnadottir: Adrenocorticotrophic hormone exerts marked lipid-lowering effects in simvastatin-treated patients. J. Int. Med. 2001, 250, 530-534.
11. Hricik, D. E., Mayes, J. T. & J. A. Schulak: Independent effects of cyclosporine and prednisone on posttransplant hypercholesterolemia. Amer. J. Kidney Dis. 1991, 18, 353-358.
12. Pacioli, R. & R. Genova: Long-term steroid-immunosuppressive treatment of the childhood nephrotic syndrome. Pediatrics 1971, 47, 731-736.
13. Peppercorn, M. A.: Advances in drug therapy for inflammatory bowel disease. Ann. Intern. Med. 1990, 112, 50-60.
14. Schapiro, R. T.: Medications used in the treatment of multiple sclerosis. Physical Medicine & Rehabilitation Clinics of North America 1999, 10, 437-446.
15. Svedmyr, N. & B. G. Simonsson: Drugs in the treatment of asthma. Pharmacology & Therapeutics - part B: General & Systematic Pharmacology 1978, 3, 397-440.
16. Vigevano, F. & M. R. Cilio: Vigabatrin versus ACTH as first-line treatment for infantile spasms: a randomised, prospective study. Epilepsia 1997, 38, 1270-1274.
17. Xu, N., Ekstrom, U. & P. Nilsson-Ehle: ACTH decreases the expression and secretion of apolipoprotein B in HepG2 cell cultures. J. Biol. Chem. 2001, 276, 38680-38684.